We are delighted to introduce you to our new RSC Pharmaceutics Advisory Board member, Dr. Marianne Ashford.
Dr. Marianne Ashford is a Senior Principal Scientist in Pharmaceutical Sciences, R&D at AstraZeneca.
Read some of Dr. Ashford’s research:
A translational framework to DELIVER nanomedicines to the clinic
Paul Joyce, Christine J. Allen, María José Alonso, Marianne Ashford, Michelle S. Bradbury, Matthieu Germain, Maria Kavallaris, Robert Langer, Twan Lammers, Maria Teresa Peracchia, Amirali Popat, Clive A. Prestidge, Cristianne J. F. Rijcken, Bruno Sarmento, Ruth B. Schmid, Avi Schroeder, Santhni Subramaniam, Chelsea R. Thorn, Kathryn A. Whitehead, Chun-Xia Zhao and Hélder A. Santos
Nat. Nanotechnol., 2024, 19, 1597
Free drug and ROS-responsive nanoparticle delivery of synergistic doxorubicin and olaparib combinations to triple negative breast cancer models
Robert J Cavanagh, Patrícia F Monteiro, Cara Moloney, Alessandra Travanut, Fatemeh Mehradnia, Vincenzo Taresco, Ruman Rahman, Stewart G Martin, Anna M Grabowska, Marianne B Ashford and Cameron Alexander
Biomater. Sci., 2024, 12, 1822
In depth characterization of physicochemical critical quality attributes of a clinical drug-dendrimer conjugate
Silvia Sonzini, Fanny Caputo, Dora Mehn, Luigi Calzolai, Sven Even Borgos, Astrid Hyldbakk, Kevin Treacher, Weimin Li, Mark Jackman, Najet Mahmoudi, M Jayne Lawrence, Claire Patterson, David Owen, Marianne Ashford and Nadim Akhtar
Int. J. Pharm., 2023, 637, 122905
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.
Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.
Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.